Q97821992

Summary

Q97821992 is an individual motion^[1].

Key Facts

• Q97821992 authored Cecilia Magnusson^[2].
• Q97821992's instance of is recorded as individual motion^[3].
• Q97821992's part of the series is recorded as motions of the 2010-2011 legislative session of the Riksdag^[4].
• Q97821992's language of work or name is recorded as Swedish^[5].
• Q97821992 was published on +2010-10-20T00:00:00Z^[6].
• Q97821992's main subject is medication^[7].
• Q97821992's work available at URL is recorded as http://data.riksdagen.se/dokument/GY02So314^[8].
• Q97821992's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GY02So314^[9].
• Q97821992's applies to jurisdiction is recorded as Sweden^[10].
• Q97821992's legal citation of this text is recorded as Mot. 2010/11:So314^[11].
• Q97821992's title is recorded as Klinisk läkemedelsprövning^[12].
• Q97821992's cites work is recorded as Q98462151^[13].
• Q97821992's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97821992's copyright status is recorded as public domain^[15].
• Q97821992's legislative committee is recorded as Committee on Health and Welfare^[16].

Body

Definition and Type

Q97821992's instance of is recorded as individual motion^[3].